Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Krebs Biochemicals & Industries Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE
Add to

31/100
61.50
2.12 (3.57%)

As on 21 Apr, 2026 | 03:40

Open Trading A/c
Day Range
58.44
62.34
L H
52 Week Range
38.33
113.50
L H
Volume
4,105
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
71 59.51 62.50 3
100 59.50 62.87 50
3 59.05 62.88 200
150 58.40 62.95 200
654 58.35 63.00 100
0 Total Total 0
Bid / Ask
0.00 / 0.00
Compare Stocks Advanced Chart
31/100
59.50
-1.00 (-1.65%)

As on 21 Apr, 2026 | 04:01

Open Trading A/c
Day Range
57.56
59.50
L H
52 Week Range
38.52
113.90
L H
Volume
184
*
i

* BSE Market Depth (21 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
71 59.51 62.50 3
100 59.50 62.87 50
3 59.05 62.88 200
150 58.40 62.95 200
654 58.35 63.00 100
0 Total Total 0
Bid / Ask
0.00 / 0.00
Compare Stocks Advanced Chart
NSE
MC Essentials
53% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Low Growth Trend Stock at Reasonable Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 59.38
          Previous Close 59.38
          Volume 4,105.00
          Value (Lacs) 2.52
            VWAP 61.44
          Beta
          Mkt Cap (Rs. Cr.) 133
          High 62.34
          Low 58.44
          UC Limit 62.34
          LC Limit 56.42
          52 Week High 113.50
          52 Week Low 38.33
          Face Value 10.00
          All Time High 236.00
          All Time Low 38.33
          20D Avg Volume 48,519
          20D Avg Delivery(%) 40.61
          Book Value Per Share --
          Dividend Yield 0.00
          TTM EPS See historical trend 0.00
          TTM PE See historical trend -- (Average PE)
          P/B See historical trend 0.00
          Sector PE 39.83

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          31/100
          Average Financial Strength, Low Growth Trend Stock at Reasonable Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 45.81% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 72.74% in Mar 2026 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          7 out of 10 years Krebs Biochemicals & Industries has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 54.72% 24.67% -16.30% (2019) -10.76% 14.04%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling

          What's your call on  today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          26 Nov, 2024

          Guttikonda Rajasekhar

          Qty 143843 Price 115.85 % Traded 0.66

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          26 Nov, 2024

          guttikonda rajasekhar

          Qty 143,843 Price 115.85 % Traded 0.00
          14 Sep, 2020

          ipca laboratories limited

          Qty 1,620,000 Price 86.00 % Traded 8.26
          6 Feb, 2020

          ipca laboratories limitedaaaci1220m

          Qty 1,370,000 Price 86.00 % Traded 8.24
          2 Apr, 2019

          ajay ravi

          Qty 19,488 Price 86.00 % Traded 0.14
          1 Apr, 2019

          ipca laboratories limited

          Qty 1,675,095 Price 86.00 % Traded 12.19
          1 Apr, 2019

          hemalata ravi

          Qty 467,124 Price 86.00 % Traded 3.40
          1 Apr, 2019

          avinash ravi

          Qty 371,451 Price 86.00 % Traded 2.70
          4 Oct, 2017

          dr r t ravi

          Qty 179,316 Price 0.00 % Traded 1.30
          + Show More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          About the Company

          Krebs Biochemicals & Industries Limited (KBIL) is an India-based company. The Company operates in the pharma segment. The Companys products include lavastatin, simvastatin and simvastatin ammonium salt. The Company specializes in the fermentation technology. The Company has two manufacturing facilities: Unit-1 at Regadichelaka, Nellore district, and Unit-2 at Kothapalli Village, Kasimkota Mandal, Vishakapatnam district. Products manufactured from Unit I facility are ephedrine, pseudoephedrine and their salts, which are used for making formulations for respiratory ailments, such as cough and cold.
          {"success":1,"data":{"address":{"address1":"Kothapalli Village,","address2":"Kasimkota Mandal,,","city":"Anakapalli Dist.","state":"Andhra Pradesh","pincode":"531031","telephone1":"08924-66808040","telephone2":"","fax1":"08924-","fax2":"","email":"investors@krebsbiochem.com","web":"http:\/\/www.krebsbiochem.com"},"management":[{"name":"R T Ravi","designation":"Chairman & Non-Exe.Director"},{"name":"Manish Kumar Jain","designation":"Managing Director & CEO"},{"name":"P K Bhattacharyya","designation":"Non Executive Director"},{"name":"Avinash Ravi","designation":"Non Executive Director"},{"name":"P M Kathariya","designation":"Independent Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524518","nseId":"KREBSBIO","series":"BE","isinid":"INE268B01013"}}}

          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • R T Ravi

              Chairman & Non-Exe.Director

            • Manish Kumar Jain

              Managing Director & CEO

            • P K Bhattacharyya

              Non Executive Director

            • Avinash Ravi

              Non Executive Director

            • P M Kathariya

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524518

            • NSE:

              KREBSBIO

            • Series

              BE

            • ISIN

              INE268B01013

          Go to Top

          Advisory Alert:

          It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347